Article Text

Download PDFPDF
Extended report
Current evidence for a strategic approach to the management of rheumatoid arthritis with disease-modifying antirheumatic drugs: a systematic literature review informing the EULAR recommendations for the management of rheumatoid arthritis
  1. R Knevel1,
  2. M Schoels2,
  3. T W J Huizinga1,
  4. D Aletaha3,
  5. G R Burmester4,
  6. B Combe5,
  7. R B Landewé6,
  8. J S Smolen3,
  9. T Sokka7,
  10. D M F M van der Heijde1
  1. 1Department of Rheumatology, Leiden University Medical Centre, Leiden, The Netherlands
  2. 22nd Department of Medicine, Centre for Rheumatic Diseases, Hietzing Hospital, Vienna, Austria
  3. 3Division of Rheumatology, Department of Internal Medicine 3, Medical University of Vienna, Austria
  4. 4Humboldt University, Department of Rheumatology and Clinical Immunology, Charite Hospital, Berlin, Germany
  5. 5Service d’Immuno-Rhumatologie, Montpellier I University, Lapeyronie Hospital, Montpellier, France
  6. 6Department of Rheumatology, University Hospital Maastricht, The Netherlands
  7. 7Department of Rheumatology, Jyväskylä Central Hospital, Jyväskylä, Finland
  1. Correspondence to Ms Rachel Knevel, Department of Rheumatology, Leiden University Medical Centre, PO Box 9600, 2300 RC Leiden, Albinusdreef 2, The Netherlands; r.knevel{at}


Objectives To perform a systematic literature review of effective strategies for the treatment of rheumatoid arthritis (RA).

Methods As part of a European League Against Rheumatism (EULAR) Task Force investigation, a literature search was carried out from January 1962 until February 2009 in PubMed/Ovid Embase/Cochrane and EULAR/American College of Rheumatism (ACR)) abstracts (2007/2008) for studies with a treatment strategy adjusted to target a predefined outcome. Articles were systematically reviewed and clinical outcome, physical function and structural damage were compared between intensive and less intensive strategies. The results were evaluated by an expert panel to consolidate evidence on treatment strategies in RA.

Results The search identified two different kinds of treatment strategies: strategies in which the reason for treatment adjustment differed between the study arms (‘steering strategies’, n=13) and strategies in which all trial arms used the same clinical outcome to adjust treatment with different pharmacological treatments (‘medication strategies’, n=7). Both intensive steering strategies and intensive medication strategies resulted in better outcome than less intensive strategies in patients with early active RA.

Conclusion Intensive steering strategies and intensive medication strategies produce a better clinical outcome, improved physical function and less structural damage than conventional steering or treatment. Proof in favour of any steering method is lacking and the best medication sequence is still not known.

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.


  • RK and MS contributed equally.

  • Competing interests None. Francis Berenbaum was the Handling Editor.

  • Provenance and peer review Not commissioned; externally peer reviewed.